Hazardous Drugs and Worker Safety: Emerging Regulations

Post by:
  • 1:27PM Apr 12, 2013
  • Comments off

In February, California introduced Assembly Bill (AB) 1202 that would require its state Occupational Safety and Health Standards Board to promulgate a standard for hazardous drugs, which includes antineoplastic agents or “chemotherapy.” If enacted, California will become the second state to regulate hazardous drug handling in the workplace, as the state of Washington passed a […]

Read More

Leading Investigations into Foreign Particulate Matter

Post by:
  • 11:24AM Mar 05, 2013
  • Comments off

In life science industries, foreign particulate matter (FPM) can affect products efficacy but more important product safety. Traditional ways of dealling with FPM are reactive in nature and are not suited to comply with a quality by design approach to manufacturing. This course will provide an overview of current FPM detection techniques and how to […]

Read More

Outbreaks Trigger Demand for Stricter Adherence to USP Sterile Compounding Guidelines

Post by:
  • 1:47PM Feb 05, 2013
  • Comments off

The United States Pharmacopeia (USP) and The National Formulary (NF) publish USP-NF, a book of standards for many areas of pharmaceuticals, medicine, and other therapeutics. Chapter 797 (USP 797), applicable to any U.S. institution that prepares, stores, or dispenses compounded sterile preparations, recommends standards for the sterile compounding environment, process and personnel. Enforcement of USP […]

Read More

Webinar: Prevent Lengthy Foreign Particulate Matter Investigations and Reduce Lost Product

Post by:
  • 12:29PM Jan 21, 2013
  • Comments off

Presented by RJ Lee Group’s Biotechnology and Pharmaceutical Services Department RJ Lee Group’s Biotechnology and Pharmaceutical Services Department invites you to join us for a free webinar on ensuring quality biopharmaceutical products throughout the manufacturing process and best practices for investigating foreign particulate matter (FPM).  The webinar will include case studies, characterization techniques derived from […]

Read More

Integrating Nanotechnology into the Life Sciences: Lessons Learned – Presented by RJ Lee Group and the Biomanufacturing Training & Education Center (BTEC), NC State University

Post by:
  • 3:29PM Aug 19, 2011
  • Comments off

Ms. Julianne Wolfe, Manager, Biotechnology & Pharmaceutical Services at RJ Lee Group, Inc., and Dr. Kristin Bunker, Senior Scientist, have been invited to conduct a seminar at the Biomanufacturing Training and Education Center (BTEC) at North Carolina State University. This seminar will present a series of targeted case studies providing insight gathered from numerous nanomaterials […]

Read More

RJ Lee Group and Biomanufacturing Training & Education Center (BTEC) Presents: Managing Foreign Particulate Matter (FPM) Investigations

Post by:
  • 3:32PM Jun 17, 2011
  • Comments off

Free Seminar: Managing Foreign Particulate Matter (FPM) Investigations An Industrial Forensic Approach to Particulate Characterization for Manufacturing and Quality Assurance Investigations Julianne Wolfe, Manager, Biotechnology & Pharmaceutical Services at RJ Lee Group, Inc., will conduct a free seminar on understanding how an Industrial Forensics approach can aid in new and existing foreign particulate matter (FPM) […]

Read More

North Carolina Chinese Business Association (NCCBA) to Present Seminar “Beyond the Horizon” The Application of Nanotechnology in Personalized Medicine

Post by:
  • 3:33PM Jun 14, 2011
  • Comments off

Nanotechnology and Personalized Medicine are two of the most rapidly developing areas of biomedical research and the most promising technologies for improving healthcare and human life. Dr. Lin Wu, Director of Biotechnology and Pharmaceutical Services at RJ Lee Group Inc., Monroeville, PA and one of the founding trustees of NCCBA will be the featured speaker in […]

Read More

Dr. Linxian (Lin) Wu Joins RJ Lee Group BioPharma Group as Director

Post by:
  • 9:29AM Apr 04, 2011
  • Comments off

(MONROEVILLE, PA – April 4, 2011)  RJ Lee Group welcomes Dr. Lin Wu as Director of Pharmaceutical and Biotechnical Services at their Monroeville headquarters. As Director, Dr. Wu will be expanding RJ Lee Group’s forensic approach to biopharma foreign particulate identification and characterization as well as nanotechnology efforts in materials characterization pertaining to product R&D […]

Read More

Journal of Oncology Pharmacy Practice (JOPP) Publishes Article on Hazardous Drug Preparation Systems Co-Authored by RJ Lee Group Scientists

Post by:
  • 9:28AM Mar 07, 2011
  • Comments off

Matthew D. Zock, CIH and Senior Scientist Keith P. Rickabaugh of RJ Lee Group, Inc. co-authored an article with Scott Soefje of the University of Texas Health Science Center that was published in the March 2011 issue of the Journal of Oncology Pharmacy Practice (JOPP). The article on closed-system transfer devices (CSTDs) is titled “Evaluation […]

Read More